Advanced Biomedical holds a performance score of 14 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Advanced Biomedical are expected to decrease at a much lower rate. During the bear market, Advanced Biomedical is likely to outperform the market. Use Advanced Biomedical jensen alpha and rate of daily change , to analyze future returns on Advanced Biomedical.
Risk-Adjusted Performance
Good
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Advanced Biomedical Technologies are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Advanced Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow
5592.00
Total Cashflows From Investing Activities
-30.7 K
Advanced
Advanced Biomedical Relative Risk vs. Return Landscape
If you would invest 0.01 in Advanced Biomedical Technologies on September 26, 2025 and sell it today you would earn a total of 0.03 from holding Advanced Biomedical Technologies or generate 300.0% return on investment over 90 days. Advanced Biomedical Technologies is currently generating 3.125% in daily expected returns and assumes 17.5368% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Advanced, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days Advanced Biomedical is expected to generate 24.63 times more return on investment than the market. However, the company is 24.63 times more volatile than its market benchmark. It trades about 0.18 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.
Advanced Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Advanced Biomedical Technologies, and traders can use it to determine the average amount a Advanced Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1782
Best Portfolio
Best Equity
Good Returns
ABMT
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average Advanced Biomedical is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Advanced Biomedical by adding it to a well-diversified portfolio.
Advanced Biomedical Fundamentals Growth
Advanced Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Advanced Biomedical, and Advanced Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Advanced Pink Sheet performance.
Assessing Advanced Biomedical's fundamental ratios provides investors with valuable insights into Advanced Biomedical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Advanced Biomedical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.
Things to note about Advanced Biomedical performance evaluation
Checking the ongoing alerts about Advanced Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Advanced Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Advanced Biomedical is way too risky over 90 days horizon
Advanced Biomedical has some characteristics of a very speculative penny stock
Advanced Biomedical appears to be risky and price may revert if volatility continues
Advanced Biomedical has high likelihood to experience some financial distress in the next 2 years
Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K.
Evaluating Advanced Biomedical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Advanced Biomedical's pink sheet performance include:
Analyzing Advanced Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Advanced Biomedical's stock is overvalued or undervalued compared to its peers.
Examining Advanced Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Advanced Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Advanced Biomedical's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Advanced Biomedical's pink sheet. These opinions can provide insight into Advanced Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Advanced Biomedical's pink sheet performance is not an exact science, and many factors can impact Advanced Biomedical's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.